Clinical Trials on Viral Tonsillitis in Canada

Total 993 results

Transgene

Completed

Non-investigational Study to Evaluate Adenovirus Serotype 5 (Ad5) Neutralizing Antibodies (nAb) in Patients With Chronic Hepatitis B Virus (HBV) Mono-infection

Chronic Hepatitis B

France, Germany, Canada
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)

Recruiting

Cellular Immuno-Therapy for COVID-19 ARDS Randomized Clinical Trial (CIRCA-19 RCT)

Covid19 | Acute Respiratory Distress Syndrome

Canada
National Institute of Allergy and Infectious Diseases...
Regeneron Pharmaceuticals

Withdrawn

Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy

Hepatitis B Virus

United States, Thailand, Canada, Brazil
Hofseth Biocare ASA
KGK Science Inc.

Completed

Investigation of the Efficacy of CARDIO Softgels PLUS Best-standard-of-care in the Recovery of Patients With COVID-19

Covid-19 | COVID

Canada, Brazil, Hungary, Mexico, Serbia
Vladimír Džavík
Canadian Institutes of Health Research (CIHR); Unity Health Toronto; University...

Recruiting

Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19 (SEMPATICO)

Myocardial Injury | Covid19

Brazil, Canada, Mexico, United Kingdom
Gilead Sciences

Completed

A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS

HIV Infections | Herpes Simplex

United States, Canada
Hospital Clinico Universitario San Cecilio

Completed

Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4

HIV Infections | Hepatitis C

Spain
Beckman Coulter, Inc.

Terminated

Clinical Performance Evaluation of DxN HBV Assay

Hepatitis B

United States, Canada
GlaxoSmithKline

Completed

Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age

Herpes Zoster | Herpes Zoster Vaccine

United States, Canada, Belgium
Kayseri City Hospital

Completed

The Effect of Azithromycin Use on Conduction System of Heart in COVID-19 Positive Children

Covid19 | Long QT Syndrome | Azithromycin Adverse Reaction

Turkey
Gilead Sciences

Completed

Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment

Chronic Hepatitis B

Korea, Republic of, Canada, Taiwan
University of Pittsburgh
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Hepatitis B Research Network Pediatric Cohort Study (HBRN)

Hepatitis B

United States, Canada
National Institute of Diabetes and Digestive and...

Completed

Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection

Hepatitis B

United States, Canada
Hoffmann-La Roche
Atea Pharmaceuticals, Inc.

Completed

Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19

COVID-19

Spain, Canada, United Kingdom, Greece, Ireland, Latvia
Imperial College London

Completed

EARSATS-19: In-ear Measurement of Blood Oxygen Saturation in COVID-19 Follow up (EARSATS-19)

Covid19 | Pulmonary Disease

United Kingdom
Universidad de Granada

Unknown

Status of People With Cerebral Palsy and Their Caregivers During COVID-19 Pandemic

Cerebral Palsy

Spain
Dynavax Technologies Corporation

Terminated

A Safety and Efficacy Study of a Single or Double Dose of HEPLISAV™ Hepatitis B Vaccine in Adults With End-Stage Renal Disease

Hepatitis B

Canada
Johns Hopkins Bloomberg School of Public Health
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Anti-HIV Medications for People Recently Infected With HIV

HIV Infections

United States, Canada
Prof. R. D. Kandou General Hospital

Completed

Ocular Trauma and COVID-19 in Indonesia

COVID-19 | Ophthalmological Disorder | Ocular Injury

Indonesia
GlaxoSmithKline

Completed

Study to Evaluate Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A When Co-administered With Pneumovax 23™ in Adults Aged 50 Years and Older

Herpes Zoster | Herpes Zoster Vaccine

United States, Estonia, Canada
Argos Therapeutics

Completed

Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption

HIV Infection

United States, Canada
Ottawa Hospital Research Institute
Ontario Lung Association

Withdrawn

A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infection

HIV Infections | Tuberculosis

Canada, South Africa
Vir Biotechnology, Inc.
GlaxoSmithKline

Completed

Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19 (COMET-PEAK)

Covid19

United States, Canada, Italy, Korea, Republic of, Spain
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant

Herpes Zoster

Spain, Taiwan, Italy, Canada, Belgium, Finland, Korea, Republic of, Panama, Czechia
Hoffmann-La Roche

Completed

A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS

HIV Infections | Cytomegalovirus Retinitis

United States, Canada
Hoffmann-La Roche

Completed

A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS

HIV Infections | Cytomegalovirus Retinitis

United States, Canada
GlaxoSmithKline

Completed

Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine

Herpes Simplex

United States, Belgium, Canada
University of Pennsylvania
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Active, not recruiting

HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B

Hepatitis B

United States, Canada
KBio Inc

Completed

KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers

Covid19

United States, Canada
Gilead Sciences

Completed

Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children

HIV Infections

United States, United Kingdom, Panama
Cytheris SA

Completed

Safety Study of IL-7 in HIV-infected Patients (Inspire)

HIV Infections | Lymphopenia

United States, France, Canada, Italy
The Hospital for Sick Children
C17 Council (regulatory sponsor)

Withdrawn

Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children (CONCOR-KIDS)

Covid-19 Infection | Hospitalized Children

Canada
ViiV Healthcare
Pfizer

Terminated

Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay

HIV Infections

United States, Canada
Sunnybrook Health Sciences Centre
Canadian Institutes of Health Research (CIHR)

Enrolling by invitation

The Canadian Respiratory Research Network Long COVID-19 Study

SARS-CoV-2 Infection | Post-acute Sequelae of SARS-CoV-2

Canada
Pharmasset

Completed

Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects

HIV Infections

United States, Argentina, Mexico, Panama
Bristol-Myers Squibb

Withdrawn

A Randomized, Open-Label Study of Daclatasvir and Sofosbuvir With or Without Ribavirin for 8 Weeks in Treatment-Naïve, Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 3

Hepatitis C

France, Canada
HealthCore-NERI
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study) (HepC)

Hepatitis C | Thalassemia

United States, United Kingdom, Canada
Bristol-Myers Squibb

Withdrawn

A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)

Hepatitis C

France, Canada
Abbott

Completed

Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects

HIV Infections

United States, Canada
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b

Canada
St. Joseph's Healthcare Hamilton
Canadian Institutes of Health Research (CIHR); McMaster University; King Abdullah...

Completed

Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 COVID-19 (COVI-PRONE) (COVI-PRONE)

COVID-19 | Covid19 | Corona Virus Infection

Canada, Saudi Arabia, United States, Kuwait
Grupo de Enfermedades Infecciosas de la Sociedad...

Unknown

Epidemiological Study to Evaluate Personality Disorders in Prison Populations in Treatment for Hepatitis C (Perseo)

Hepatitis C, Chronic | Personality Disorders in Prison

Spain
Cairo University
Zagazig University

Completed

COVID-19 Impact on Rheumatic Patients

COVID

Egypt
Glaxo Wellcome

Unknown

A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients

HIV Infections | Herpes Simplex | Herpes Genitalis

United States, Canada
IrsiCaixa

Withdrawn

Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell Transplantation (ITATI)

HIV Infection

Spain, Netherlands, Italy
University of Stirling
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique... and other collaborators

Unknown

Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC (MobEboDRC)

Malaria | Yellow Fever | Ebola Virus Disease | Typhoid Fever | Dengue Fever | Chikungunya Fever

Canada, Congo, The Democratic Republic of the, Germany, Senegal
University Health Network, Toronto
CIHR Canadian HIV Trials Network

Completed

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals? (VALIDATE)

HIV Infections | HIV Infection | Herpes Simplex Type II

Canada, United Kingdom, Argentina, Brazil
University of Calgary
Health Canada

Completed

PERC Health Canada COVID-19

COVID-19 | SARS-CoV-2 Infection

Canada
Vaxxinity, Inc.
Syneos Health; Coalition for Epidemic Preparedness Innovations

Active, not recruiting

Platform Trial to Compare Homologous Boost of Authorized COVID-19 Vaccines and Heterologous Boost With UB-612 Vaccine

COVID-19 Vaccines

Philippines, United States, Panama
Kirby Institute

Completed

Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection. (REACT)

Hepatitis C

Australia, United States, United Kingdom, New Zealand, Switzerland, Canada, Germany, Netherlands

Clinical Trials on Viral Tonsillitis in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations